ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2026
Transarterial chemoembolization with radioactive seed implantation for multitumor hepatocellular carcinoma.
Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTransarterial chemoembolization (TACE) combined with radioactive seed implantation has emerged as an effective locoregional strategy for treating hepatocellular carcinoma (HCC). Nevertheless, evidence supporting the use of this combined approach in patients with multitumor HCC remains limited.
aimWe aimed to evaluate the effectiveness and safety of TACE in combination with radioactive seed implantation for multitumor HCC. MATERIALS AND
methodsThis retrospective study analyzed consecutive patients with multitumor HCC who underwent TACE with or without radioactive seed implantation at our institutions between January 2022 and December 2024. Clinical data, therapeutic responses, long-term outcomes, and treatment-related adverse events were collected and compared between the 2 cohorts.
resultsA total of 120 individuals were enrolled, of whom 59 were treated with TACE alone, and 61 with TACE combined with radioactive seed implantation. The 2 groups were comparable in terms of demographics and clinical characteristics at baseline. As compared with TACE monotherapy, the combined treatment group demonstrated better total response rate (49.2% vs 30.5%;
conclusionsIn comparison with TACE alone, TACE combined with radioactive seed implantation significantly enhances treatment efficacy without compromising safety in patients with multitumor HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.